389
Participants
Start Date
July 31, 2005
Primary Completion Date
May 31, 2006
BEA 2180 BR
tiotropium
UAB Lung Health Center, Birmingham
Vapahcs 111P, Palo Alto
Boehringer Ingelheim Investigational Site, San Diego
GLAHS Sepulveda, Sepulveda
Rehabilitation Clinical Trial Center, Torrance
Boehringer Ingelheim Investigational Site, Wheat Ridge
Hospital for Special Care, New Britain
Bay Pines VA Medical Center, Bay Pines
Boehringer Ingelheim Investigational Site, Panama City
Boehringer Ingelheim Investigational Site, Pembroke Pines
Boehringer Ingelheim Investigational Site, Coeur d'Alene
LSUHSC - Shreveport, Shreveport
VAMC-Reno, Reno
North Shore Universtiy Hospital, New Hyde Park
SVMMC, Toledo
Boehringer Ingelheim Investigational Site, Medford
Hershey Medical Center, Hershey
Boehringer Ingelheim Investigational Site, Philadelphia
Frank Sciurba, Pittsburgh
Boehringer Ingelheim Investigational Site, Charleston
MUSC, Charleston
Boehringer Ingelheim Investigational Site, Spartanburg
Boehringer Ingelheim Investigational Site, Harker Heights
MEDVAMC, Houston
McGuire VA, Fredericksburg
Boehringer Ingelheim Investigational Site, Richmond
Boehringer Ingelheim Investigational Site, Tacoma
CHU du Sart Tilman (B35), Angleur
A.Z. VUB, Brussels
UZ Antwerpen, Edegem
AZ Jan Palfijn, Ghent
UZ Gent, Ghent
Virga Jesseziekenhuis, Hasselt
Clinique Reine Astrid, Malmedy
Heilig Hartziekenhuis, Menen
Sint-Elisabethziekenhuis, Turnhout
Ziekenhuisgroep Twente, Almelo
Amphia Ziekenhuis, Breda
Tjongerschans Ziekenhuis, Heerenveen
Atrium Medisch Centrum, Heerlen
Ziekenhuisgroep Twente, Hengelo
Academisch Ziekenhuis Nijmegen St. Radbout, Nijmegen
Gelre Ziekenhuizen, Zutphen
Lead Sponsor
Boehringer Ingelheim
INDUSTRY